-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Vir Biotechnology, Inc. quarterly and annual Depreciation history and change rate from 2022 to Q3 2025.
- Vir Biotechnology, Inc. Depreciation for the quarter ending 30 Sep 2025 was $2,900,000, unchanged year-over-year.
- Vir Biotechnology, Inc. Depreciation for the twelve months ending 30 Sep 2025 was $11,300,000, a 28% decline year-over-year.
- Vir Biotechnology, Inc. annual Depreciation for 2024 was $14,200,000, a 25% decline from 2023.
- Vir Biotechnology, Inc. annual Depreciation for 2023 was $18,900,000, a 200% increase from 2022.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)